Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 29 (1) , e29-e38
Abstract
No abstract availableKeywords
Funding Information
- Ontario Ministry of Health and Long-Term Care (MOHLTC)
This publication has 26 references indexed in Scilit:
- Validation of colorectal cancer surgery data from administrative data sourcesBMC Medical Research Methodology, 2012
- Adherence to Stage-Specific Treatment Guidelines for Patients With Colon CancerJournal of Clinical Oncology, 2012
- Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2012
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic FeaturesJournal of Clinical Oncology, 2011
- Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon CancerJournal of the American Geriatrics Society, 2009
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerJournal of Clinical Oncology, 2004
- Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site GroupJournal of Clinical Oncology, 2004
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon CancerJournal of Clinical Oncology, 2002
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992